EMVision Medical Devices Ltd (EMV.AX)
AUD 1.75
(-6.91%)
AUD 1.75
(-6.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -2.09 Million AUD | 40.14% |
| 2023 | -3.49 Million AUD | -3.54% |
| 2022 | -7.83 Million AUD | -1.52% |
| 2021 | -9.55 Million AUD | -96.94% |
| 2020 | - AUD | -72.84% |
| 2019 | - AUD | -121.25% |
| 2018 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -2.6 Million AUD | 0.0% |
| 2024 FY | - AUD | -23.43% |
| 2024 Q2 | -6.12 Million AUD | 0.0% |
| 2023 Q2 | -5.56 Million AUD | 0.0% |
| 2023 FY | - AUD | -3.54% |
| 2023 Q4 | -5.02 Million AUD | 0.0% |
| 2022 FY | - AUD | -1.52% |
| 2022 Q2 | -5.34 Million AUD | 0.0% |
| 2022 Q4 | -4.87 Million AUD | 0.0% |
| 2021 Q2 | -4.86 Million AUD | 0.0% |
| 2021 FY | - AUD | -96.94% |
| 2021 Q4 | -5.2 Million AUD | 0.0% |
| 2020 FY | - AUD | -72.84% |
| 2020 Q4 | -2.18 Million AUD | 0.0% |
| 2020 Q2 | 3268.00 AUD | 0.0% |
| 2019 Q4 | -333.00 AUD | 99.95% |
| 2019 Q3 | -739.65 Thousand AUD | -172715.48% |
| 2019 Q2 | -428.00 AUD | 0.0% |
| 2019 FY | - AUD | -121.25% |
| 2018 Q2 | -12.00 AUD | -100.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q1 | -6.00 AUD | 0.0% |
| 2018 Q4 | -441.00 AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 94.202% |
| Adherium Limited | -11.56 Million AUD | 81.917% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 71.587% |
| Atomo Diagnostics Limited | -5.42 Million AUD | 61.442% |
| Anteris Technologies Ltd | -66.9 Million AUD | 96.874% |
| Control Bionics Limited | -5.15 Million AUD | 59.459% |
| CardieX Limited | -6.71 Million AUD | 68.843% |
| Compumedics Limited | 2.78 Million AUD | 174.981% |
| Cochlear Limited | 579.5 Million AUD | 100.361% |
| CleanSpace Holdings Limited | -3.49 Million AUD | 40.111% |
| Cyclopharm Limited | -3.03 Million AUD | 31.095% |
| Nova Eye Medical Limited | -5.97 Million AUD | 65.024% |
| HeraMED Limited | -3.97 Million AUD | 47.352% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 90.438% |
| ImpediMed Limited | -22.05 Million AUD | 90.516% |
| InhaleRx Limited | -1.41 Million AUD | -47.92% |
| LBT Innovations Limited | -4.04 Million AUD | 48.352% |
| Micro-X Limited | -14.35 Million AUD | 85.428% |
| Neurotech International Limited | -8.24 Million AUD | 74.634% |
| OncoSil Medical Limited | -11.97 Million AUD | 82.539% |
| PolyNovo Limited | 5.17 Million AUD | 140.449% |
| Respiri Limited | -7.04 Million AUD | 70.337% |
| SomnoMed Limited | -2.32 Million AUD | 10.195% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 76.996% |
| Uscom Limited | -1.5 Million AUD | -38.554% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | 57.473% |